Related Experiment Videos
Crohn's disease and IL-10 therapy: promise regained
1Inflammatory Bowel Disease Program, Division of Digestive Diseases and Nutrition, University of Kentucky, Lexington, USA.
Inflammatory Bowel Diseases
|June 12, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Serum Amyloid A Promotes Inflammation-Associated Damage and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer.
Cellular and molecular gastroenterology and hepatology·2021
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2021
The Link Between Bacterial Inflammagens, Leaky Gut Syndrome and Colorectal Cancer.
Current medicinal chemistry·2021
Serum amyloid A and inflammasome activation: A link to breast cancer progression?
Cytokine & growth factor reviews·2020
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.
Inflammatory bowel diseases·2026
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.
Inflammatory bowel diseases·2026
Novel proteomic signatures of stricturing Crohn disease using a treatment-naive cohort.
Inflammatory bowel diseases·2026
Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysis.
Inflammatory bowel diseases·2026
The Relationship Between Dietary Intake and Meal Timing on Sleep Behaviors in Professional Male Rugby League Athletes.
International journal of sports physiology and performance·2026
Early Postoperative Nutritional Management Under a Validated Diabetes-Specific Enhanced Recovery After Surgery Protocol in Patients With Lumbar Spinal Stenosis and Type 2 Diabetes Mellitus.
Journal of investigative surgery : the official journal of the Academy of Surgical Research·2026
Gut microbiota dysbiosis and joint diseases: advances in the gut-joint axis.
Frontiers in immunology·2026